Skip to main content
Premium Trial:

Request an Annual Quote

BGI, U of Birmingham Create Environmental Omics Center in UK

NEW YORK (GenomeWeb) – BGI and the University of Birmingham have partnered to create the Joint Centre for Environmental Omics (JCEO), which will analyze the toxicity of compounds to protect health, the environment, and global biodiversity, the university said today.

The joint facility will be based at Birmingham's campus at Edgbaston, UK, and will be operated with the BGI China National GeneBank (CNGB). Lab technicians and bioinformaticians from BGI will collaborate with Birmingham scientists and international partners. They will use automated high-throughput sample processing to investigate the effects that thousands of high priority chemicals and advanced materials have on biological systems.

There are currently more than 60,000 synthetic compounds in use by industries, but there is a shortage of information about their effects on health and the environment, the university said. This center will aim to take advantage of rapid improvements in genome sequencing and computing to study the safety of these chemicals, and to help industries fulfill the requirements of European Union chemical safety legislation.

"In collaboration with industry and government scientists, the JCEO will allow the European Union and beyond to 'industrialize' knowledge for advancing regulatory science and its applications that will, in turn, lead to a unique mass-scale predictive, quick, and relatively inexpensive diagnoses of environmental health concerns," JCEO Co-director and CNGB Deputy Director Xin Zhou said in a statement.

Officials from the university and BGI signed the agreement to create the new center on July 3.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.